Literature DB >> 16796224

Zolpidem tartrate use as contributory factor in sinus disease.

Kelly M Malloy, Julie Ketrick, Edmund A Pribitkin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16796224     DOI： 10.1093/sleep/29.6.849

Source DB:  PubMed          Journal:  Sleep        ISSN： 0161-8105            Impact factor:   5.849


× No keyword cloud information.
  2 in total

1.  Hypnotics and infections: disproportionality analysis of the U.S. Food & Drug Administration adverse event reporting system database.

Authors:  Long Meng; Jing Huang; Qin He; Yibei Zhao; Wenlong Zhao; Juntao Tan; Shusen Sun; Junqing Yang
Journal:  J Clin Sleep Med       Date:  2022-09-01       Impact factor: 4.324

Review 2.  Meta-analyses of hypnotics and infections: eszopiclone, ramelteon, zaleplon, and zolpidem.

Authors:  Florendo L Joya; Daniel F Kripke; Richard T Loving; Arthur Dawson; Lawrence E Kline
Journal:  J Clin Sleep Med       Date:  2009-08-15       Impact factor: 4.062
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.